NEW ORLEANS (Reuters) - Pfizer Inc's Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and naproxen, and does not ...

Jeffrey Brown talks with health correspondent Susan Dentzer and Dr. John Reveille, director of the Division of Rheumatology at the University of Texas Health Science Center in Houston, about the ...

New research suggests that top-selling pain reliever Celebrex does not carry the same heart attack risk as Vioxx, a similar drug pulled from the market in September because of safety concerns.

NEW YORK (AP) - Pfizer Inc. said Friday its pain reliever Celebrex showed no increased overall risk of cardiovascular problems in a massive analysis of 41 completed studies involving 44,000 patients.

For more than a decade, Pfizer’s blockbuster Celebrex has been nagged by the perception that extended use of the arthritis drug carried an increased risk for heart problems. It has outlasted its ...

Advertisements for the arthritis drug Celebrex were misleading and unsubstantiated, overstating the pain reliever’s benefits and understating the risks, the government said Wednesday. Subscribe to ...

Pfizer says a study found an increased risk of heart problems with the painkiller Celebrex. The news comes after another painkiller, Vioxx, was withdrawn from the market. Like Vioxx, Celebrex is in a ...